The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes

Published:2017-08 Issue:2 Volume:26 Page:343-352.e2
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Frias Juan Pablo,Bastyr Edward J.,Vignati Louis,Tschöp Matthias H.,Schmitt Christophe,Owen Klara,Christensen Rune Haubo,DiMarchi Richard D.

Funder

AbbVie

AstraZeneca

Boehringer Ingelheim

BMS

Elcelyx

Eli Lilly & Co.

Ionis

Janssen

Johnson and Johnson

Ligand

Merck

Mylan

Novartis

Novo Nordisk

Pfizer

Sanofi

Theracos

vTv

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference47 articles.

1. Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors;Aaboe;Diabetes Obes. Metab.,2015

2. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

3. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab.,2013

4. TCF1 links GIPR signaling to the control of beta cell function and survival;Campbell;Nat. Med.,2016

5. Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes;Chia;Diabetes,2009

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management;Nature Metabolism;2024-08-19

2. The role of incretin receptor agonists in the treatment of obesity;Diabetes, Obesity and Metabolism;2024-07-29

3. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists;Frontiers in Endocrinology;2024-07-24

4. Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity;Expert Opinion on Investigational Drugs;2024-07-17

5. Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group;Diabetes Therapy;2024-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3